Archives
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-21
The Hoechst 33342/PI Double Staining Kit supports fluorescence-based separation of normal, apoptotic-like, and membrane-compromised cell populations using nuclear morphology and PI uptake. It is intended for scientific research workflows, not diagnostic or medical use, and should be interpreted with appropriate controls because dye patterns alone do not establish a complete mechanism of cell death.
-
SAPC-LNP mRNA Vaccines and Immune Memory
2026-09-20
The reference study introduces SAPC-LNPs, which combine sialic-acid targeting with cleavable PEG to improve dendritic-cell delivery, endosomal escape, and the durability of mRNA cancer vaccination. Its central finding is that durable protection depends on strong immune memory against tumor antigens while limiting immune memory against the lipid nanoparticle carrier.
-
Phosbind Biotin for Phosphorylation Detection
2026-09-19
Phosbind Biotin is a sequence-independent reagent for Western Blot detection of phosphorylated proteins on PVDF membranes. Its dinuclear metal complex phosphate binding chemistry connects membrane-based detection with protein phosphorylation analysis in signal transduction pathway research.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-18
Use dual fluorescence to separate mRNA uptake from functional translation in delivery screens, macrophage studies, and carrier optimization. This practical workflow combines Cy5-based tracking with EGFP expression to reveal where a formulation succeeds—or fails—in the delivery pathway.
-
Testosterone Bounce in Degarelix-Treated Prostate Cancer
2026-09-18
A 2024 retrospective study identified testosterone bounce, defined using a 20 ng/dL threshold, as a prognostic marker in prostate cancer patients receiving degarelix. The association with overall and cancer-specific survival suggests that serial testosterone kinetics may provide information beyond a single castration-level measurement, although the finding requires prospective validation.
-
Nanozymes Target Intramacrophage Bacteria in CRC
2026-09-17
The reference study develops a mannose-targeted, self-activatable polymeric nanozyme that combines ferrocene chemistry with artesunate to eliminate intracellular Fusobacterium nucleatum in colorectal cancer-associated macrophages. By reducing a bacterial driver of immunosuppression, the platform reprograms the macrophage ecosystem and improves the response to CD47 blockade in tumor models.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Assay Logic
2026-09-17
EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5 tracking with Firefly Luciferase translation to separate cellular uptake, intracellular release, and protein expression. This guide presents a mechanistic assay framework for mRNA delivery and transfection, reporter interpretation, and in vivo study design.
-
ROS-Mediated Metabolic Rewiring in Melanoma
2026-09-16
Cesi et al. showed that BRAF or MEK inhibition increases reactive oxygen species, activates pyruvate dehydrogenase kinases, and suppresses PDH-dependent oxidative metabolism in melanoma cells. The work identifies PDK inhibition as a potential metabolic vulnerability in BRAF-mutant and BRAF inhibitor-resistant melanoma, while also clarifying how treatment-induced stress can reshape tumor-cell growth.
-
Regorafenib: From Kinase Breadth to RRM2
2026-09-16
Regorafenib is more than a broad-spectrum kinase tool. Emerging melanoma data connect its multikinase activity with RRM2 suppression and ERK/E2F3 modulation, creating a practical framework for mechanism-led cancer biology research and translational study design.
-
VX-661: A Mechanism-First CFTR Assay Framework
2026-09-15
VX-661, a F508del CFTR corrector, is best evaluated by separating CFTR folding, surface delivery, and channel function. This mechanism-first guide translates calnexin-dependent variant research into practical assay design and interpretation for cystic fibrosis research.
-
Resazurin sodium salt: Practical Cell Assay Guide
2026-09-15
Build more reliable metabolic, proliferation, and cytotoxicity workflows with Resazurin sodium salt while controlling solvent, exposure time, and redox-related artifacts. The guide translates glutamine-metabolism findings in hepatic stellate cells into practical assay design without confusing metabolic signal with direct cell counting or pathway flux.
-
A-1210477: MCL-1 Inhibitor Research Guide
2026-09-14
A-1210477 is a potent, selective MCL-1 inhibitor for mechanistic cancer research. It disrupts MCL-1–BIM signaling and supports apoptosis studies in MCL-1-dependent cells, but its reported pharmacokinetic limitations restrict direct in vivo interpretation.
-
Artificial Photoreceptors with Biomimetic Adaptation
2026-09-14
Zhang and colleagues developed a ferroelectric-liquid metal hybrid film that converts visible and near-infrared light into bioelectrical signals while reproducing scotopic and photopic adaptation without external circuitry. In retinal-degeneration models, the implant restored visible-light sensitivity, enabled infrared perception, and remained integrated and biocompatible for three months, supporting further development of flexible retinal prostheses.
-
EZ Cap EGFP mRNA 5-moUTP Workflow Guide
2026-09-13
Learn how to use EZ Cap EGFP mRNA 5-moUTP as a stable fluorescent reporter for delivery, translation, viability, and imaging studies. The workflow also translates machine-learning-guided lipid nanoparticle findings into practical assay design and troubleshooting decisions.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-12
Zhang et al. show that CDC42-dependent epithelial polarity controls the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–epiregulin–mTOR axis that operates independently of canonical Wnt signaling. The study connects epithelial architecture to crypt proliferation and provides a genetic and pharmacological framework for dissecting intestinal renewal mechanisms.